✉news BusinessStartups first seen 5 d ago, last 5 d ago, peak #11
GTH weighs investment in radiopharmaceutical cancer diagnostics startup
Original: GTH is examining an investment in a BioTech startup with a disruptive radiopharmaceutical for cancer diagnostics
GTH is reviewing a potential investment in a biotech startup developing a radiopharmaceutical for cancer diagnostics. The company describes the candidate technology as disruptive, and the move would mark an entry into the fast-growing nuclear medicine space. Details on the size of the investment, the identity of the startup, and the stage of the technology have not been disclosed.
Why now: News of a potential deal in the high-interest radiopharmaceutical sector is drawing investor attention.
Rank over time, top of the chart is #1. 6 snapshots from 5 d ago to 5 d ago.
Evidence
- GTH is examining an investment in a BioTech startup with a disruptive radiopharmaceutical for cancer diagnostics · TradingView
API: https://socialmediatrends-api.osmike.com/v1/trends/1335519